Cogentix Medical (CGNT) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Roth Capital Upgrades Cogentix Medical (CGNT) to Buy
November 5, 2015 7:24 AM ESTRoth Capital upgraded Cogentix Medical (NASDAQ: CGNT) from Neutral to Buy with a price target of $3.00 (from $1.85).
Analyst Chris Lewis commented, "Given our confidence for CGNT to sustain double-digit revenue growth with opportunities for acceleration as EndoSheath sales productivity materializes, paired with notable... More
